Dr. Reddys Laboratories Ltd.

BSE: 500124 | NSE: DRREDDY
Mid Cap | Pharmaceuticals & Drugs
1234.60
-10.90 (-0.88%)
< Home < Back

Dr.Reddy's Laboratories informs about board meeting proceedings

Date: 27-07-2021
Dr.Reddy's Laboratories has informed that the Board of Directors of the Company at their meeting held on July 27, 2021 have approved the Unaudited Financial Results of the Company for the quarter ended June 30, 2021. In terms of the above, it enclosed the following: Unaudited Consolidated Financial Results of the Company and its subsidiaries for the quarter ended June 30, 2021 prepared in compliance with International Financial Reporting Standards (IFRS) as issued by International Accounting Standards Board (IASB); Press Release on Financial Results of the Company for the above period; and etc.

The above information is a part of company’s filings submitted to BSE.